1,000 new jobs in Galway as DexCom officially breaks ground on manufacturing site in Athenry


On Friday January 19, DexCom, global leader in real-time continuous glucose monitoring for people with diabetes, announced it has officially broken ground on its new state-of-the-art manufacturing facility, located in Athenry.

The firm has also announced a partnership with Connacht Rugby, meanwhile, in a move that will see the Sportsground renamed officially as Dexcom Stadium.

This week’s news marks the second step in the realisation of this facility, which is expected to bring more than 1,000 jobs to the area and represents one of the biggest single private sector investments ever in the West of Ireland.

The 1,000 jobs will include support in finance, HR, as well as a variety of engineering roles, ranging from leadership to graduate positions.

Dexcom also intends to build strong links with the local universities in Galway and nearby counties, particularly around engineering and quality assurance courses. In an additional boost to the local economy, it is expected that for every job created by Dexcom a further 1 – 1.7 jobs will be created indirectly in the regional economy.

Dexcom has also announced a 12-year naming-rights partnership with Connacht Rugby. From today, ‘The Sportsground’ will be known as ‘Dexcom Stadium’, which has been the home of Connacht Rugby since 1927.

Barry Regan, Executive Vice President of Operations at Dexcom, said: “The creation of the Dexcom manufacturing facility will undoubtedly be a gamechanger for the West of Ireland.

“This is a pivotal moment for Dexcom and we are confident it will have an immensely positive impact in Galway and the wider region too, not only in relation to job creation but also as we become part of and contribute to this community. We’re already proud to be partnering with Connacht Rugby, and this is only the beginning”.

Michael Lohan, CEO of IDA Ireland, added: “The sod turning event is an important moment in this facility – first announced last year – becoming a reality. This important strategic investment by Dexcom, which is the first of its kind outside of the US, will have far reaching economic and social benefits for Athenry, the West and indeed all of Ireland. I wish continued success to Dexcom and assure the team of IDA Ireland’s continued support.

Dexcom’s first manufacturing facility in Europe will ensure the flow of products throughout EMEA, with the potential to lower the cost of goods and improve sustainability by decreasing delivery time in transit. The new facility will have the capacity to produce millions of Dexcom rtCGM sensors each year, helping to improve the lives of people with diabetes in EMEA.

This project is supported by the Irish Government through IDA Ireland.


Leave a Reply

Your email address will not be published. Required fields are marked *